Stock Movers

Weekly Roundup: FICO Jumps, Carnival Slides, Pfizer Soars

Oct 3, 2025
This week highlights FICO's innovative direct-to-lender pricing model, enabling mortgage lenders to bypass credit bureaus. Carnival's stock tumbled after disappointing fourth-quarter guidance raised concerns over cost pressures, despite some analyst optimism. Meanwhile, Pfizer drove a surge in pharmaceutical stocks by securing a deal to reduce drug prices for Medicaid recipients in exchange for tariff relief and a significant investment in the U.S. These developments are shaping the market landscape.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

FICO Disrupts Credit Score Distribution

  • FICO will sell credit scores directly to mortgage resellers, reducing reliance on credit bureaus.
  • The move can cut bureaus' markup fees while charging $33 per borrower at loan close.
INSIGHT

Carnival Pullback After Guidance And Cost Worries

  • Carnival's shares fell about 6.7% after weak fourth-quarter guidance and 2026 cost headwinds.
  • Analysts still defend the stock and expect ways to offset rising costs despite the pullback.
INSIGHT

Pfizer Deal Spurs Pharma Rally

  • Pfizer led pharma gains after a deal with the U.S. government easing drug-pricing and tariff pressures.
  • The company agreed to price cuts for Medicaid and a three-year tariff reprieve plus $70 billion US investment.
Get the Snipd Podcast app to discover more snips from this episode
Get the app